{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-153622","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2021-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.284166+00:00","generated_at":"2026-06-27T22:23:00.340809+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Petros Pharmaceuticals raises $7.5M in registered direct offering and private placement","bullets":["Sold 2,186,589 shares at $3.43 each to accredited investors, including largest shareholder.","Issued warrants to purchase up to 1,639,942 shares at $3.50, exercisable for five years.","Net proceeds expected ~$6.9M after fees; used for men's health platform expansion and working capital.","Katalyst Securities served as financial advisor; receives $560K fee and 110,000 warrants.","Closing occurred December 27, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-153622","json":"https://secwatch.observer/filing/0001104659-21-153622.json","markdown":"https://secwatch.observer/filing/0001104659-21-153622.md","text":"https://secwatch.observer/filing/0001104659-21-153622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465921153622/0001104659-21-153622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465921153622/tm2136334d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:23:00.340809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}